Highest Risk Classification
The U.S. Food and Drug Administration (FDA) has officially designated the recall of approximately 19 million eggs as a Class I event, the highest risk classification available to the agency. This designation indicates a “reasonable probability” that the consumption of the affected products will cause serious adverse health consequences or death. The move follows a voluntary recall initiated on July 22 by Midwest Poultry Services (MPS) after potential Salmonella Enteritidis contamination was detected at two Texas production facilities.
Scope of the Outbreak
Data provided by the Centers for Disease Control and Prevention (CDC) indicates that the contaminated eggs have been linked to at least 98 confirmed cases of salmonellosis across 17 states. As of the most recent reporting on July 24, approximately 26 individuals have required hospitalization due to severe illness. The outbreak has prompted a broad regulatory response to prevent further infections.
Affected Products and Distribution
The recalled products include both white shell eggs and brown cage-free shell eggs produced at the Texas facilities between June 6 and July 3, 2026. These eggs were distributed to retail outlets and food service operators across several states, including Texas, Oklahoma, Arkansas, Louisiana, New Mexico, and Mississippi. Consumers are advised to check cartons for sell-by or best-by dates ranging from July 20 to August 17, 2026.
Consumer and Industry Guidance
The FDA’s Class I mandate places an urgent responsibility on retailers and restaurant operators to immediately cease the sale and service of the affected inventory. Consumers who have these eggs in their households are instructed to dispose of them immediately or return them to the point of purchase for a full refund. Furthermore, the agency emphasizes the necessity of cleaning and sanitizing any surfaces, containers, or utensils that may have come into contact with the recalled products to prevent cross-contamination.
Midwest Poultry Services has stated that it initiated the recall as a precautionary measure and is currently conducting rigorous testing protocols to identify the specific source of the pathogen within its production cycle. The company is cooperating with federal regulators to mitigate the impact on the supply chain while prioritizing public safety.